5 References

  • 1
    Bjoraker, J. A., Ryu, J. H., Edwin, M. K., Myers, J. L., Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care. Med. 1998, 157, 199203.
  • 2
    Naik, P. K., Moore, B. B., Viral infection and aging as cofactors for the development of pulmonary fibrosis. Expert Rev. Respir. Med. 2010, 4, 759771.
  • 3
    Raghu, G., Freudenberger, T. D., Yang, S., Curtis, J. R. et al., High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir. J. 2006, 27, 136142.
  • 4
    King, T. E., Pardo, A., Selman, M., Idiopathic pulmonary fibrosis. Lancet 2011, 378, 19491961.
  • 5
    Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J. et al., An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 2011, 183, 788824.
  • 6
    Noble, P. W., Albera, C., Bradford, W. Z., Costabel, U. et al., Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 2011, 377, 17601769.
  • 7
    Abrahamson, M., Alvarez-Fernandez, M., Nathanson, C-M., Cystatins. Biochem. Soc. Symp. 2003, 70, 179199.
  • 8
    Turk, V., Bode, W., The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett. 1991, 285, 213219.
  • 9
    Rawlings, N. D., Barrett, A. J., Bateman, A., MEROPS: the database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res. 2012, 40, 343350.
  • 10
    Wallin, H., Bjarnadottir, M., Vogel, L. K., Wassélius, J. et al., Cystatins-Extra- and intracellular cysteine protease inhibitors: high-level secretion and uptake of cystatin C in human neuroblastoma cells. Biochimie 2010, 92, 16251634.
  • 11
    Abrahamson, M., Barrett, A. J., Salvesen, G., Grubb, A., Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J. Biol. Chem. 1986, 261, 1128211289.
  • 12
    Turk, V., Stoka, V., Turk, D., Cystatins: biochemical and structural properties, and medical relevance. Front. Biosci. J. 2008, 13, 54065420.
  • 13
    Lalmanach, G., Diot, E., Godat, E., Lecaille, F. et al., Cysteine cathepsins and caspases in silicosis. Biol. Chem. 2006, 387, 863870.
  • 14
    Kasabova, M., Saidi, A., Naudin, C., Sage, J. et al., Cysteine cathepsins: markers and therapy targets in lung disorders. Clin. Rev. Bone Miner. Metab. 2011, 9, 148-161.
  • 15
    Odutayo, A., Cherney, D., Cystatin C and acute changes in glomerular filtration rate. Clin. Nephrol. 2012, 78, 6475.
  • 16
    Grubb, A., Non-invasive estimation of glomerular filtration rate (GFR). The Lund model: Simultaneous use of cystatin C- and creatinine-based GFR-prediction equations, clinical data and an internal quality check. Scand. J. Clin. Lab. Invest. 2010, 70, 6570.
  • 17
    Bollengier, F., Cystatin C, alias post-gamma-globulin: a marker for multiple sclerosis? J. Clin. Chem. Clin. Biochem. 1987, 25, 589593.
  • 18
    Takeuchi, M., Fukuda, Y., Nakano, I., Katano, Y. et al., Elevation of serum cystatin C concentrations in patients with chronic liver disease. Eur. J. Gastroenterol. Hepatol. 2001, 13, 951955.
  • 19
    Chu, S.-C., Wang, C.-P., Chang, Y.-H., Hsieh, Y.-S. et al., Increased cystatin C serum concentrations in patients with hepatic diseases of various severities. Clin. Chim. Acta 2004, 341, 133138.
  • 20
    Gressner, A. M., Lahme, B., Meurer, S. K., Gressner, O. et al., Variable expression of cystatin C in cultured trans-differentiating rat hepatic stellate cells. World J. Gastroenterol. 2006, 12, 731738.
  • 21
    Chung-Hung, T., Shun-Fa, Y., Yu-Chao, C., The upregulation of cystatin C in oral submucous fibrosis. Oral Oncol. 2007, 43, 680685.
  • 22
    Ley, B., Ryerson, C. J., Vittinghoff, E., Ryu, J. H. et al., A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012, 156, 684691.
  • 23
    Naser, N., Clinical Chemistry Laboratory Manual, Mosby: St Louis, Missouri 1998.
  • 24
    Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T. et al., A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 1999, 130, 461470.
  • 25
    Quesnel, C., Marchand-Adam, S., Fabre, A., Marchal-Somme, J. et al., Regulation of hepatocyte growth factor secretion by fibroblasts in patients with acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294, 334343.
  • 26
    Serveau-Avesque, C., Martino, M. F.-D., Hervé-Grépinet, V., Hazouard, E. et al., Active cathepsins B, H, K, L and S in human inflammatory bronchoalveolar lavage fluids. Biol. Cell 2006, 98, 1522.
  • 27
    Perdereau, C., Godat, E., Maurel, M.-C., Hazouard, E. et al., Cysteine cathepsins in human silicotic bronchoalveolar lavage fluids. Biochim. Biophys. Acta 2006, 1762, 351356.
  • 28
    Naudin, C., Joulin-Giet, A., Couetdic, G., Plésiat, P. et al., Human cysteine cathepsins are not reliable markers of infection by Pseudomonas aeruginosa in cystic fibrosis. Plos One. 2011, 6, e25577.
  • 29
    Lecaille, F., Naudin, C., Sage, J., Joulin-Giet, A. et al., Specific cleavage of the lung surfactant protein A by human cathepsin S may impair its antibacterial properties. Int. J. Biochem. Cell Biol. 2013, 45, 17011709.
  • 30
    Chang, J. C., Lesser, M., Yoo, O. H., Orlowski, M., Increased cathepsin B-like activity in alveolar macrophages and bronchoalveolar lavage fluid from smokers. Am. Rev. Respir. Dis. 1986, 134, 538541.
  • 31
    Ishii, Y., Hashizume, Y., Watanabe, T., Waguri, S. et al., Cysteine proteinases in bronchoalveolar epithelial cells and lavage fluid of rat lung. J. Histochem. Cytochem. 1991, 39, 461468.
  • 32
    Lüthgens, K., Ebert, W., Trefz, G., Gabrijelcic, D. et al., Cathepsin B and cysteine proteinase inhibitors in bronchoalveolar lavage fluid of lung cancer patients. Cancer Detect. Prev. 1993, 17, 387397.
  • 33
    Reilly, J. J. Jr, Chen, P., Sailor, L. Z., Wilcox, D. et al., Cigarette smoking induces an elastolytic cysteine proteinase in macrophages distinct from cathepsin L. Am. J. Physiol. 1991, 261, 4148.
  • 34
    Takahashi, H., Ishidoh, K., Muno, D., Ohwada, A. et al., Cathepsin L activity is increased in alveolar macrophages and bronchoalveolar lavage fluid of smokers. Am. Rev. Respir. Dis. 1993, 147, 15621568.
  • 35
    Schiffl, H., Lang, S. M., Update on biomarkers of acute kidney injury: moving closer to clinical impact? Mol. Diagn. Ther. 2012, 16, 199207.
  • 36
    Lecaille, F., Kaleta, J., Brömme, D., Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design. Chem. Rev. 2002, 102, 44594488.
  • 37
    Reiser, J., Adair, B., Reinheckel, T., Specialized roles for cysteine cathepsins in health and disease. J. Clin. Invest. 2010, 120, 34213431.
  • 38
    Turk, V., Stoka, V., Vasiljeva, O., Renko, M. et al., Cysteine cathepsins: From structure, function and regulation to new frontiers. Biochim. Biophys. Acta 2012, 1824, 6888.
  • 39
    Bühling, F., Röcken, C., Brasch, F., Hartig, R. et al., Pivotal role of cathepsin K in lung fibrosis. Am. J. Pathol. 2004, 164, 22032216.
  • 40
    Bühling, F., Waldburg, N., Reisenauer, A., Heimburg, A. et al., Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation. Eur. Respir. J. 2004, 23, 620628.
  • 41
    Zhang, D., Leung, N., Weber, E., Saftig, P. et al., The effect of cathepsin K deficiency on airway development and TGF-β1 degradation. Respir. Res. 2011, 12, 72.
  • 42
    Zhang, D., Huang, C., Yang, C., Liu, R. J. et al., Antifibrotic effects of curcumin are associated with overexpression of cathepsins K and L in bleomycin treated mice and human fibroblasts. Respir. Res. 2011, 12, 154.